EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression

Fanbin Zeng, Cheng Chen, Zhanwei Fu, Haihui Huang, Wenqiang Cui, Yuanyuan Zhou, Yanjie Kong, Xia Liu, Zhiru Xu, Shouguo Wang, Tian Xiao, Houjun Xia

Cellular Oncology · 2025

DOI: 10.1007/s13402-025-01111-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Fanbin Zeng und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Carbolines, Colorectal Neoplasms, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-mdm2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbolinesColorectal NeoplasmsTumor Suppressor Protein p53Proto-Oncogene Proteins c-mdm2Signal TransductionAlkaloidsDisease ProgressionHumansAnimalsApoptosisCell ProliferationXenograft Model Antitumor AssaysCell Line, TumorMice, NudeMiceMice, Inbred BALB CCell Cycle CheckpointsCell SurvivalUbiquitination

Stichwörter der Autor:innen

Colorectal cancerMDM2-p53 pathwaySmall-molecule compoundsβ-carboline alkaloid

Substanzen

CarbolinesTumor Suppressor Protein p53Proto-Oncogene Proteins c-mdm2AlkaloidsMDM2 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China.
  • Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen, Guangdong, 518107, China.
  • Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
  • College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, 518060, China.
  • Pathology Department, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, No. 3002 Shungang West Road, Shenzhen, 518035, China.
  • National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, 200437, China.

Zitieren

APA

Zeng, F., Chen, C., Fu, Z., Huang, H., Cui, W., Zhou, Y., Kong, Y., Liu, X., Xu, Z., Wang, S., Xiao, T., & Xia, H. (2025). A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression. Cellular Oncology. https://doi.org/10.1007/s13402-025-01111-3

Vancouver

Zeng F, Chen C, Fu Z, Huang H, Cui W, Zhou Y, et al. A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression. Cellular Oncology. 2025. doi:10.1007/s13402-025-01111-3

BibTeX
@article{Zeng2025,
  author = {Zeng, Fanbin and Chen, Cheng and Fu, Zhanwei and Huang, Haihui and Cui, Wenqiang and Zhou, Yuanyuan and Kong, Yanjie and Liu, Xia and Xu, Zhiru and Wang, Shouguo and Xiao, Tian and Xia, Houjun},
  title = {A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-025-01111-3}
}
Kostenlos starten →